News | September 16, 2025
Cadila launches nutritional replenisher ‘Nu Nutridac’ capsule
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Replicate will receive research funding and could potentially receive up to approximately US$550 million
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Based on the CRL, the STARGLO data do not provide sufficient evidence to support the proposed second-line DLBCL indication in the US patient population
Celecoxib is a nonsteroidal anti-inflammatory drug
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than R-GemOx
Isotretinoin capsules are indicated to treat severe, disfiguring nodular acne
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
Subscribe To Our Newsletter & Stay Updated
